| Early-Phase Clinical Studies Worldwide |
![]() |
![]() |
|
Talk to Us Now!
|
Start UpClinical Trials Management for Start -Up Companies Fledgling biotechnology and start-up companies face different challenges than established pharmaceutical companies. Their reality mandates a different way of thinking and doing, a more "Thinking-Out-Of-The-Box" approach. Throughout years of experience we at TransCom have developed tools and infrastructure that are specifically-designed to support these types of companies in successfully bringing their clinical development stages from Phase I to Phase II and from Phase II to Phase III. Why Should Start-Up Companies Choose TransCom?
Our Special Approach for Fledgling Start-Up Companies TransCom works in close cooperation with start-ups right from the start, offering:
TransCom supports clients throughout the entire clinical development stage by characterizing and identifying the client's needs in order to maximize the success of this stage.
|
Our Clients
|

